Dätwyler Holding has placed a CHF 240 million fixed rate bond on 15 June 2022. The bond bears interest of 2.1% and has a term of five years. Zürcher Kantonalbank managed the placement of the bond based
Tags :Kellerhals Carrard
Fema Retail acquired all shares in Ladenbau Schmidt from the Schmidt family last 13th of May. The purchase price was highly leveraged by UBS Switzerland and additionally financed by a seller’s loan. Ladenbau Schmidt,
Swiss watchmaker Greubel Forsey Holding has completed the acquisition of shares held by a minority shareholder in Greubel Forsey and GFPI. Greubel Forsey Holding now holds the entire share capital of Greubel Forsey and GFPI.
Focus Financial Partners, an international partnership of independent, fiduciary wealth management firms, has expanded its global footprint to Switzerland with the acquisition of Octogone group. At the end of April, Focus announced that it has
Kellerhals Carrard acted as Swiss legal advisor to MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company elevating care with innovative immunology therapeutics, in the closing of its previously announced business combination with Helix Acquisition Corp. (“Helix”), a
Kellerhals Carrard acted as legal advisors to the Leemann family on the sale of the Beausite Park Hotel in Wengen to Montelago Hospitality Group. Thus the succession for the traditional hotel in the Jungfrau region
Kellerhals Carrard partner Ingrid Iselin (pictured) has been re-elected to the Contentious Trusts and Estates Global SIG Steering Committee. STEP Contentious Trusts and Estates Global SIG focuses on expertise and best practice
Senectovia, a provider of products and services in the field of decubitus prophylaxis and therapy, mobilisation and obesity care. The medical technology company founded in 1980 was taken over by a family office as part of
Kellerhals Carrard has announced the appointment of eight new partner and three new counsels. Meet the new partners Martin Föhse first joined Kellerhals Carrard in 2015. He specialises in constitutional and administrative law. He advises
Vifor Pharma Group closed its divestment transaction regarding its finished drug product manufacturing business with facilities in Fribourg, Ettingen (both in Switzerland) and Lisbon (Portugal) to CordenPharma, a full-service Contract Development & Manufacturing Organisation (CDMO)
